Compare Five9 Inc (FIVN) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Five9 Inc vs Tenet Healthcare Corporation — how do they compare? Five9 Inc trades at $31.48 (market cap $2.44B), while Tenet Healthcare Corporation trades at $264 (market cap $20.89B). The key difference: Tenet Healthcare Corporation is far larger — about 8.6× Five9 Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Five9 Inc nearer its low. Which is the better fit depends on your goals.
| FIVN | THC | |
|---|---|---|
Market Cap | $2.44B | $20.89B |
Sector | Technology | Health |
52-Week High | $34.48 | $262.63 |
52-Week Low | $13.61 | $161.37 |
Enterprise Value | $2.59B | $31.97B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Five9 (FIVN) trades at $34.48, up 1.44% today and near its 52-week high of $34.58. The stock shows strong technical momentum with bullish moving averages and has beaten earnings estimates for three consecutive quarters. Revenue growth accelerated to 10% in Q2 2026, driven by AI-powered subscription services, while profitability improved with net income turning positive in 2025 after years of losses.
Outlook remains positive with 61% analyst buy ratings and a consensus price target of $32.67, though current price exceeds this target. Key risks include high valuation multiples (P/E 48), ongoing legal scrutiny regarding fiduciary duties, and competitive pressures in the CX software space. The company's leadership refresh and AI integration provide growth catalysts.
Tenet Healthcare (THC) trades at $260.67, up 0.28% today, with strong technical momentum including a golden cross pattern and bullish moving average alignment. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $6.12 versus $4.26 forecast, maintaining a three-quarter earnings beat streak. Valuation metrics remain attractive with P/E of 10.03 and EV/EBITDA of 5.73, while profitability metrics show exceptional ROE of 53.31% and net margin of 9.9%.
The investment outlook remains positive with 81% analyst buy ratings and $281.44 consensus price target representing 8% upside. Key risks include policy headwinds in ACA exchanges and hospital segment challenges, though strong ambulatory growth provides offset. The stock presents a compelling value-growth combination with momentum characteristics, supported by institutional accumulation and positive earnings revisions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Five9 Inc
Five9 provides cloud-native contact center software that enables digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement capabilities, and various software modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's artificial intelligence and automation portfolio supplements and enhances the firm's core CCaaS offerings, including solutions for digital self-service, agent assist technology, and workflow automation. Five9 also offers workforce optimization products that optimize call center efficiency through workforce management solutions, manage interaction quality, and track agent performance.
Read more on FIVN →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
